PGxBridge is a healthcare systems strategy project focused on accelerating pharmacogenomic adoption in the Australian healthcare system. Rather than positioning precision medicine as a standalone testing product, the project reframed the challenge as a clinical workflow and reimbursement problem. The proposed solution embedded genomic intelligence directly into electronic prescribing through trigger-based testing, rapid PGx pipelines, clinician-facing decision support, and a staged reimbursement pathway involving pilot subsidies, insurer co-funding, and eventual MBS integration.

The project combined healthcare strategy, policy analysis, health economics, and clinical workflow design to develop a scalable national precision-prescribing infrastructure model. Core work included stakeholder alignment, implementation roadmap design, CDS workflow prototyping, ROI modelling, and pilot planning around high-risk medications such as clopidogrel. The final proposal positioned PGxBridge as a healthcare transformation infrastructure layer rather than a consumer-facing medical app.

slide-01.png

slide-02.png

slide-03.png

slide-04.png

slide-05.png

slide-06.png

slide-07.png

slide-08.png

slide-09.png

slide-10.png

slide-11.png

slide-12.png

slide-13.png

slide-14.png

slide-15.png